SAB Biotherapeutics SABS
NASDAQ SABS
$3.11 +0.04 (+1.30%)
At close: Nov 11, 2026 · 4:00 PM EST

SAB Biotherapeutics (SABS) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

SAB Biotherapeutics (SABS) reported Return on Capital Employed [ROCE] of -31.01% for Q2 2026, up 147.36 percentage points from -178.37% a year earlier but down 2.03 percentage points from the prior quarter.

Analysis

SAB Biotherapeutics (SABS) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, SAB Biotherapeutics posted Return on Capital Employed [ROCE] of -50.04%, up 26.46 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a four-year change of -18.44 percentage points (FY2021 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -76.50% in FY2024 (-9.25 pp), -67.26% in FY2023 (-10.59 pp), -56.67% in FY2022 (-25.07 pp) and -31.60% in FY2021.
  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of -178.37% in Q2 2025 and a high of -18.45% in Q4 2021.
  • Year over year, Return on Capital Employed [ROCE] has now increased in each of the last four quarters, with an average year-over-year change of +25.91 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q2 2026 (a gain of 147.36 percentage points); the low point was Q2 2025 (a drop of 100.86 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -28.98% (Q1 2026), -29.23% (Q4 2025) and -44.99% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 SAB Biotherapeutics 279.79 Mn -130.87 Mn - -38.29%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -38.29%
Jun 30, 2026 -31.01%
Mar 31, 2026 -28.98%
Dec 31, 2025 -29.23%
Sep 30, 2025 -44.99%
Jun 30, 2025 -178.37%
Mar 31, 2025 -134.24%
Dec 31, 2024 -104.62%
Sep 30, 2024 -105.60%
Jun 30, 2024 -77.50%
Mar 31, 2024 -60.65%
Dec 31, 2023 -84.00%
Sep 30, 2023 -119.33%
Jun 30, 2023 -105.35%
Mar 31, 2023 -89.40%
Dec 31, 2022 -78.77%
Sep 30, 2022 -73.09%
Jun 30, 2022 -51.70%
Mar 31, 2022 -37.65%
Dec 31, 2021 -18.45%
API Access

SAB Biotherapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SABS&period=max&api_key=YOUR_API_KEY